跳至主要内容
临床试验/NCT05686421
NCT05686421终止不适用

A Single-Center Proof Of Concept Study of a Novel Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configuration Devices

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2023年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
42
试验地点
1
主要终点
Percentage of Participants Who Indicate Device N Provided a More Comfortable Experience, Compared With Device C

研究概览

简要总结

In this study, participants will be imaged using two Optical Coherence Tomography (OCT) devices: device N, a standard conventional OCT device with an invention (comfortable chin and forehead rest that can be adjusted to fit each individual's size) attached to the device; and device C, the standard conventional OCT device with no invention attached. The investigators will assess whether the chin and forehead rest attachment (invention) provides a more comfortable experience for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers; OR,
  • AMD, diabetic retinopathy, central serous chorioretinopathy, and/or glaucoma or glaucoma suspects or any other suspected eye disease
  • Group-Specific Inclusion Criteria:
  • - There are no group-specific inclusion criteria for patients with AMD, diabetic retinopathy, and central serous chorioretinopathy.
  • Healthy Volunteers
  • A normal clinical ophthalmic examination.
  • Reliable VF, reproducible glaucoma hemifield tests labeled within normal limits on at least one test.
  • Good quality (adequate signal strength ≥ 6/10, without segmentation algorithm failure and motion artifacts > 1 vessel diameter) RNFL and Ganglion Cell Inner Plexiform Layer (GCIPL) OCT, within normal limits.
  • Primary Open Angle Glaucoma (POAG)
  • Clinical characteristics of glaucoma: optic nerve head (ONH) abnormalities: global rim thinning, rim notch, or disc hemorrhage; retinal nerve fiber layer (RNFL) defect.
  • Typical glaucomatous field loss in reliable VF, reproducible glaucoma hemifield tests labeled outside normal limits on at least two consecutive tests.
  • Good quality (adequate signal strength ≥ 6/10, without segmentation algorithm failure and motion artifacts > 1 vessel diameter) RNFL and GCIPL OCT, labeled outside normal limits with typical glaucomatous RNFL and GCIL thinning.
  • Normal Tension Glaucoma (NTG)
  • Identical to POAG criteria with IOP recorded at ≤ 21 mmHg at any time point.

排除标准

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Any medical treatment (e.g., chronic corticosteroid, hydroxychloroquine, chloroquine, thioridazine, canthaxanthine) or conditions that affect VF (e.g., stroke) and retinal thickness other than glaucoma.

结局指标

主要结局

Percentage of Participants Who Indicate Device N Provided a More Comfortable Experience, Compared With Device C

时间窗: Post-Imaging Session (Day 1)

Participants will be asked which device provided a more comfortable experience: Device C or Device N.

Comfort Level Rating of Device N on 0-5 Scale

时间窗: Post-Imaging Session (Day 1)

Participants will be asked to rate how comfortable Device N was, on a scale of 0-5. Higher scores indicate higher levels of comfort.

Comfort Level Rating of Device C on 0-5 Scale

时间窗: Post-Imaging Session (Day 1)

Participants will be asked to rate how comfortable Device C was, on a scale of 0-5. Higher scores indicate higher levels of comfort.

次要结局

  • Time Duration to Adjust for Number of Motion Artifacts Present With Device N Imaging(Imaging Session (Day 1))
  • Time Duration to Adjust for Number of Motion Artifacts Present With Device C Imaging(Imaging Session (Day 1))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验